What To Know About Goldman Sachs's Downgrade of Sema4 Holdings

Goldman Sachs downgraded its rating of Sema4 Holdings SMFR to Neutral with a price target of $1.00, changing its price target from $3.00 to $1.00.

Shares of Sema4 Holdings are trading down 6.35% over the last 24 hours, at $0.28 per share.

A move to $1.00 would account for a 252.86% increase from the current share price.

About Sema4 Holdings

Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.